Year 2013 Number of articles 45 Title of study. Journal. Authors
(alphabetic order)
CPE authors Research area
1
The Asian
Pharmacoepidemiology Network (AsPEN):
promoting multi-national collaboration for
pharmacoepidemiologic research in Asia.
Pharmacoepidemiology and drug safety.
Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Jalbert J, Kimura M,
Kimura T, Kubota K, Lai E. C, Ooba N, Park B. J, Pratt N, Roughead E. E, Sato T,
Setoguchi S, Shin J. Y, Sundstrom A, Yang Y. H.
Andersen M, Bergman U, Sundstrom A.
-
2
Pharmacological treatment and demographic
characteristics of pediatric patients with Attention Deficit Hyperactivity Disorder, Sweden.
European
neuropsychopharmacology : the journal of the
European College of
Neuropsychopharmacology.
Bahmanyar S, Sundstrom A, Kaijser M, von Knorring AL, Kieler H.
Bahmanyar S,
Sundstrom A, Kieler H.
Reproductive
pharmacoepidemiology.
3
Non-steroidal anti- inflammatory drugs and venous thromboembolism in women.
Pharmacoepidemiology and drug safety.
Bergendal A, Adami J, Bahmanyar S,
Hedenmalm K, Larfars G, Persson I,
Sundstrom A, Kieler H.
Bergendal A, Bahmanyar S,
Sundstrom A, Kieler H.
Cardiovascular diseases and drugs.
4
Fear of childbirth in expectant fathers, subsequent childbirth experience and impact of antenatal education:
subanalysis of results from a randomized controlled trial. Acta obstetricia et gynecologica Scandinavica.
Bergstrom M, Rudman A, Waldenstrom U, Kieler H.
Kieler H. Reproductive
pharmacoepimemiology
5
Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register. Clinical epidemiology.
Bergdahl J, Jarnbring F, Ehrenstein V,
Gammelager H, Granath F, Kieler H, Svensson M, Tell G. S, Lagerros YT.
Granath F, Kieler H, Lagerros YT.
Chronic diseases and biologics.
6
A comparison of
cardiovascular risk factors for ten antipsychotic drugs in clinical practice.
Neuropsychiatric disease and treatment.
Boden R, Edman G, Reutfors J, Ostenson CG, Osby U.
Boden R, Reutfors J. CNS and drugs.
7
Lower rate of cardiovascular
complications in patients on bolus insulin analogues:
a retrospective population-
Cammarota S, Falconio LM, Bruzzese D,
Catapano AL, Casula M, Citarella A, De Luca L, Flacco M. E,
Citarella A. Chronic diseases and biologics.
based cohort study. PloS one.
Manzoli L, Masulli M, Menditto E, Mezzetti A, Riegler S, Novellino E, Riccardi G.
8
High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total
population of Stockholm, Sweden - a challenge for public health. BMC public health.
Carlsson AC, Wandell P, Osby U, Zarrinkoub R, Wettermark B, Ljunggren G.
Wettermark B. Chronic diseases and biologics.
CNS and drugs.
Cardiovascular diseases and drugs.
9
Extraction of electronic health record data in a hospital setting:
comparison of automatic and semi-automatic methods using anti-TNF therapy as model. Basic &
clinical pharmacology &
toxicology.
Cars T, Wettermark B, Malmstrom RE, Ekeving G, Vikstrom B,
Bergman U, Neovius M, Ringertz B,
Gustafsson L. L.
Wettermark B, Bergman U.
Chronic diseases and biologics.
10
Initiating therapy with antidepressants after discontinuation of hormone therapy. Menopause.
Citarella A, Andersen M, Sundstrom A, Bardage C, Hultman CM, Kieler H.
Citarella A, Andersen M, Sundstrom A, Kieler H.
Reproductive
pharmacoepidemiology
11
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and
Forslund T,
Wettermark B, Wandell P, von Euler M,
Wettermark B. Cardiovascular diseases and drugs.
without access to primary healthcare data: experience from the Stockholm health care system. International journal of cardiology.
Hasselstrom J, Hjemdahl P.
12
The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PloS one.
Hagg D, Eriksson M, Sundstrom A, SchmittEgenolf M.
Hagg D, Sundstrom A. Chronic diseases and Biologics.
13
Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal
osteoporosis in the Danish National Registry of Patients. Clinical epidemiology.
Gammelager H,
Svaerke C, Noerholt SE, Neumann-Jensen B, Xue F, Critchlow C, Bergdahl J, Lagerros YT, Kieler H, Tell GS, Ehrenstein V.
Lagerros YT, Kieler H. Reproductive
pharmacoepimemiology
14
Changes in the utilization of venlafaxine after the introduction of generics in Sweden. Applied health economics and health policy.
Godman B, Persson M, Miranda J, Skiold P, Wettermark B, Barbui C, Gustafsson L. L.
Wettermark B. -
15
Placental weight and mortality in premenopausal breast cancer by tumor characteristics. Breast
Hajiebrahimi MH, Bahmanyar S, Lambe M, Adolfsson J,
Fornander T, Wärnberg F, Cnattingius S.
Hajiebrahimi MH, Bahmanyar S.
Cancer and drugs.
cancer research and treatment.
16
Breast cancer risk in opposite-sexed twins:
influence of birth weight and co-twin birth weight.
Journal of the National Cancer Institute.
Hajiebrahimi M, Bahmanyar S, Oberg S, Iliadou AN, Cnattingius S.
Hajiebrahimi M, Bahmanyar S.
Cancer and drugs.
17
Socioeconomic status and the quality of prescribing asthma drugs in Sweden.
The Journal of asthma : official journal of the Association for the Care of Asthma.
Heibert Arnlind M, Wettermark B, Sjoborg B, Dahlen E, Loikas D, Wikstrom Jonsson E.
Wettermark B, Dahlen E, Loikas D.
Chronic diseases and biologics.
18
Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly. BMJ Open.
Helldén A, Odar- Cederlöf I, Nilsson G, Sjöviker S, Söderström A, Euler Mv, Ohlén G, Bergman U.
Bergman U. -
19
Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper
gastrointestinal
complications. European journal of gastroenterology
& hepatology.
Jonasson C, Hatlebakk JG, Lundell L, Kouri JP, Andersen M, Granath F.
Andersen M, Granath F.
Chronic diseases and biologics.
20
Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.
Current drug safety.
Karlstad O, Starup- Linde J, Vestergaard P, Hjellvik V, Bazelier MT, Schmidt MK, Andersen M, Auvinen A, Haukka J, Furu K, de Vries F, De Bruin ML
Andersen M. Chronic diseases and biologics
21
[Birth control pills, surgery and casting leads to high risk of venous thrombosis in women. Better
prophylaxis is needed for surgical procedures, as shown in case-control study]. Lakartidningen.
Kieler H, Persson I, Sundstrom A, Hedenmalm K, Odeberg J, Bergendal A.
Kieler H, Sundstrom A, Bergendal A.
Reproductive
pharmacoepidemiology.
22
HPV-genotypes in high- grade intraepithelial cervical lesions in Danish women. Acta obstetricia et gynecologica Scandinavica.
Kirschner B,
Schledermann D, Holl K, Rosenlund M, Raillard A, Quint W, Molijn A, Jenkins D, Junge J.
Rosenlund M. Cancer and drugs.
23
HPV genotypes in invasive cervical cancer in Danish women. Acta obstetricia et gynecologica Scandinavica.
Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D,
Schledermann D.
Rosenlund M. Cancer and drugs.
24
Treatment with finasteride and prostate cancer survival. Scandinavian journal of urology.
Kjellman A, Friis S, Granath F, Gustafsson O, Sorensen HT, Akre O.
Granath F. Cancer and drugs
25
Differences in drug utilisation between men and women: a cross- sectional analysis of all dispensed drugs in Sweden.
BMJ open.
Loikas D, Wettermark B, von Euler M, Bergman U, Schenck- Gustafsson K.
Loikas D, Wettermark B, Bergman U.
-*
26
Trends in the lifetime risk of COPD exacerbation
requiring hospitalisation.
The European respiratory journal.
Lykkegaard J, dePont Christensen R, Davidsen JR, Stovring H, Andersen M, Sondergaard J.
Andersen M. Chronic diseases and biologics.
27
Respiratory infections in preterm infants and subsequent asthma: a cohort study. BMJ open.
Montgomery S, Bahmanyar S, Brus O, Hussein O, Kosma P, Palme-Kilander C.
Bahmanyar S. Reproductive
pharmacoepidemiology.
Chronic diseases and biologics.
28
Mortality following a brain tumour diagnosis in patients with multiple sclerosis. BMJ open.
Montgomery S, Hassan A, Bahmanyar S, Brus O, Hussein O, Hiyoshi A, Hillert J, Olsson T, Fall K.
Bahmanyar S. Cancer and drugs
29
Validation of asthma and eczema in population- based Swedish drug and patient registers.
Pharmacoepidemiology and drug safety.
Ortqvist AK, Lundholm C, Wettermark B, Ludvigsson JF, Ye W, Almqvist C.
Wettermark B. Chronic diseases and biologics.
30
Trends in antiarrhythmic drug use after marketing authorization of
dronedarone: comparison between Emilia Romagna (Italy) and Sweden.
European journal of clinical pharmacology.
Piccinni C, Raschi E, Poluzzi E, Puccini A, Cars T, Wettermark B, Diemberger I,
Boriani G, De Ponti F.
Wettermark B. Cardiovascular diseases and drugs
31
Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study. British journal of clinical
pharmacology.
Pottegard A, Friis S, Andersen M, Hallas J.
Andersen M. Cancer and drugs.
32
Multi-country rapid adverse drug event assessment: the Asian
Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study.
Pharmacoepidemiology and drug safety.
Pratt N, Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Kimura M, Kimura T, Kubota K, Lai EC, Ooba N, Osby U, Park BJ, Sato T, Shin JY,
Sundström A, Yang YH, Roughead EE.
Andersen M, Bergman U, Sundström A.
CNS and drugs
Cardiovascular diseases and drugs
33
Persistence to
antihypertensive drug treatment in Swedish primary healthcare.
European journal of clinical pharmacology.
Qvarnstrom M, Kahan T, Kieler H, Brandt L, Hasselstrom J,
Bengtsson Bostrom K, Manhem K, Hjerpe P, Wettermark B.
Qvarnstrom M, Kieler H, Brandt L,
Wettermark B.
Cardiovascular diseases and drugs.
34
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PloS one.
Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M, Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F.
Wettermark B. CNS and drugs.
35
Medication and suicide risk in schizophrenia: a nested case-control study.
Schizophrenia research.
Reutfors J, Bahmanyar S, Jonsson EG, Brandt L, Boden R, Ekbom A, Ösby U.
Reutfors J, Bahmanyar S, Brandt L, Boden R.
CNS and drugs.
36
Antipsychotic prescription filling in patients with schizophrenia or
schizoaffective disorder.
Journal of clinical psychopharmacology.
Reutfors J, Brandt L, Stephansson O, Kieler H, Andersen M, Boden R.
Reutfors J, Brandt L, Kieler H, Andersen M, Boden R.
CNS and drugs.
37
Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women.
Thrombosis research.
Sonnevi K, Bergendal A, Adami J, Larfars G, Kieler H.
Bergendal A, Kieler H. Reproductive
pharmacoepidemiology.
38
Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. Jama.
Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M,
Norgaard M, Nielsen R. B, Zoega H,
Valdimarsdottir U.
Kieler H, Haglund B. Reproductive
pharmacoepidemiology.
39
The burden of rotavirus gastroenteritis and
hospital-acquired rotavirus gastroenteritis among children aged less than 6 years in Japan: a
retrospective, multicenter epidemiological survey.
BMC pediatrics.
Tajiri H, Takeuchi Y, Takano T, Ohura T, Inui A, Yamamoto K, Higashidate Y,
Kawashima H, Toyoda S, Ushijima K,
Ramakrishnan G, Rosenlund M, Holl K.
Rosenlund M. -
40
Adherence to preventive statin therapy according to socioeconomic position.
European journal of clinical pharmacology.
Wallach-Kildemoes H, Andersen M,
Diderichsen F, Lange T.
Andersen M. Cardiovascular diseases and drugs.
41
Drug treatment in older people before and after the transition to a multi-dose drug dispensing system--a longitudinal analysis. PloS one.
Wallerstedt SM, Fastbom J, Johnell K, Sjoberg C, Landahl S, Sundstrom A.
Sundstrom A. -
42
Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011. Family practice.
Wandell P, Carlsson AC, Wettermark B, Lord G, Cars T, Ljunggren G.
Wettermark B. -
43
The intriguing future of pharmacoepidemiology.
European journal of clinical pharmacology.
Wettermark B. Wettermark B. -
44
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Pharmacoepidemiology and drug safety.
Wettermark B, Zoega H, Furu K, Korhonen M, Hallas J, Norgaard M, Almarsdottir A, Andersen M,
Andersson Sundell K, Bergman U, et al.
Wettermark B,
Andersen M, Bergman U, Kieler H.
-
45
The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. European journal of heart failure.
Zarrinkoub R,
Wettermark B, Wandell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T.
Wettermark B. Cardiovascular diseases and drugs.
